The results from other studies have shown increased SOD activity in colon samples from patients with colon cancer at stages I and III when compared to the control group, whereas the lower SOD activity was demonstrated in patients with colon cancer at stage IV [26,27]. The gene discussed is SOD1; the disease is colonic neoplasm.